Term Gallery logo

Significados de non-alcoholic steatohepatitis em inglês

Nonalcoholic fatty liver disease that is characterized by the presence of inflammation with hepatocyte injury such as ballooning, with or without any fibrosis.

Veja mais
Uso de non-alcoholic steatohepatitis em inglês
1
We present a 47-year-old Caucasian female with ESLD secondary to non-alcoholic steatohepatitis and HPS.
Pubmed
2
The inflammatory component of non-alcoholic steatohepatitis (NASH) can lead to irreversible liver damage.
Pubmed
3
Only in the last few years has non-alcoholic steatohepatitis been recognized as an important and relatively common liver disease.
Pubmed
4
Several lines of epidemiological evidence have suggested that non-alcoholic steatohepatitis (NASH) is closely associated with obesity in humans.
Pubmed
5
The present study aimed to investigate the effects of LRP and LQP on non-alcoholic steatohepatitis (NASH) in a mouse model.
Pubmed
6
Aims: To determine the presence of steatosis and non-alcoholic steatohepatitis in chronic hepatitis C and its correlation with genotype and hepatic fibrosis.
Pubmed
7
Although the exact cause of cryptogenic cirrhosis is unknown, there are correlations that non-alcoholic steatohepatitis (NASH) plays a dominant role.
Pubmed
8
However, approved anti-inflammatory therapies are not currently available for the prevention of the transition from simple steatosis to non-alcoholic steatohepatitis (NASH).
Pubmed
9
Despite the consistent rise of non-alcoholic steatohepatitis (NASH) worldwide, the mechanisms that govern the inflammatory aspect of this disease remain unknown.
Pubmed
10
Background: Saturated fatty acids are toxic to liver cells and are believed to play a central role in the pathogenesis of non-alcoholic steatohepatitis.
Pubmed
11
Due to the obesity epidemic, non-alcoholic steatohepatitis (NASH) is a prevalent liver disease, characterized by fat accumulation and inflammation of the liver.
Pubmed
12
Non-alcoholic steatohepatitis (NASH) is one of the most common liver disorders.
Pubmed
13
Non-alcoholic steatohepatitis (NASH) will likely become the leading indication for liver transplantation in the future.
Pubmed
14
Background and aim: Non-alcoholic steatohepatitis (NASH) is predicted to become the most common cause of cirrhosis and liver failure.
Pubmed
15
Lay summary: Non-alcoholic steatohepatitis is a chronic liver disease that is associated with an increased risk of developing cirrhosis and cardiovascular disease.
Pubmed
16
NASH, formally known as non-alcoholic Steatohepatitis, is seen as one of the fastest growing diseases in the developed world with no approved treatments.
Reuters
Esta colocação é formada por:
Non-alcoholic steatohepatitis nas variantes da língua
Estados Unidos da América
Comum